← 返回前沿论文

新型仿生纳米平台放大铁死亡以特异性激活 cGAS-STING 通路增强肝细胞癌化疗-免疫治疗

英文原题:A novel biomimetic nanoplatform amplifies ferroptosis for specific cGAS-STING pathway activation to enhance hepatocellular carcinoma chemo-immunotherapy.

PubMed 2025/11/25(内容时间) J Nanobiotechnology Q1 · IF 15(JCR 2025)

研究概要

低免疫原性仍然是肝细胞癌(HCC)有效免疫治疗的关键障碍。

中文摘要

低免疫原性仍然是肝细胞癌(HCC)有效免疫治疗的关键障碍。激活环鸟苷酸-腺苷酸合成酶-干扰素基因刺激因子(cGAS-STING)通路是HCC治疗的一种有前景的策略;然而,实现该通路的特异性激活仍然是一个重大挑战。在此,我们报道了一种新型仿生纳米平台(PZ@M-T),其通过触发铁死亡来特异性激活cGAS-STING通路。本研究利用中空ZIF-8金属有机框架(MOF)包覆间充质干细胞膜(MSCm)作为仿生载体,负载通过无铜点击化学功能化三苯基膦(TPP)的巴黎 polyphyllin II(PP),用于线粒体靶向。肿瘤微环境(TME)中酸响应性PP释放诱导HCC细胞发生强烈的铁死亡,引发线粒体应激导致内源性线粒体DNA(mtDNA)释放,在Zn2+的协同下特异性启动cGAS-STING通路。这种激活驱动树突状细胞(DC)成熟,将肿瘤相关巨噬细胞(TAMs)从M2型重极化为M1型,增强细胞毒性T细胞浸润,并抑制调节性T细胞(Tregs),从而共同驱动强大的抗肿瘤免疫反应,显著抑制HCC进展。这一创新的纳米治疗平台通过特异性激活cGAS-STING通路为肿瘤免疫治疗提供了新的有前景的策略,并为晚期化学-免疫治疗策略提供了新见解。

展开英文摘要原文

Low immunogenicity remains a critical barrier to effective immunotherapy for hepatocellular carcinoma (HCC). Activating the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway is a promising strategy for HCC treatment; however, achieving specific activation of this pathway remains a major challenge. Herein, we report a novel biomimetic nanoplatform (PZ@M-T) that triggers ferroptosis to specifically activate the cGAS-STING pathway. This study utilized a hollow ZIF-8 metal-organic framework (MOF) coated with mesenchymal stem cell membrane (MSCm) as a biomimetic carrier of polyphyllin II (PP ) functionalized with triphenylphosphine (TPP) via copper-free click chemistry for mitochondrial targeting. Acid-responsive PP release in the tumor microenvironment (TME) induced robust ferroptosis in HCC cells, eliciting mitochondrial stress to cause endogenous mitochondrial DNA (mtDNA) release, which specifically initiated the cGAS-STING pathway with the cooperation of Zn 2+ . This activation drove dendritic cell (DC) maturation, repolarized tumor-associated macrophages (TAMs) from the M2 to M1 phenotype, enhanced cytotoxic T cell infiltration, and suppressed regulatory T cells (Tregs), thereby collectively driving a robust anti-tumor immune response that significantly inhibited HCC progression. This innovative nanotherapeutic platform provides new promising strategy for tumor immunotherapy via specific activation of the cGAS-STING pathway and offers new insights into advanced chemo-immunotherapeutic approaches.

论文信息

作者
Peng H、Chang A、Zhang H、Xu X、Wang W、Zhang K、Yang J、Xie S
第一作者单位
School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.China
通讯作者单位
School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. dxiaoxv@163.com.China
期刊
Journal of nanobiotechnology2025 Nov 25
原文标识
PubMed 41291739 · DOI 10.1186/s12951-025-03870-5